Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Stock Short Interest Declines 46.6%

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totaling 143,564 shares, a drop of 46.6% from the September 15th total of 268,742 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 239,833 shares, the days-to-cover ratio is presently 0.6 days.

Xtant Medical Stock Performance

Shares of Xtant Medical stock traded down $0.00 on Wednesday, hitting $0.32. The stock had a trading volume of 28,906 shares, compared to its average volume of 646,391. Xtant Medical has a twelve month low of $0.27 and a twelve month high of $0.95. The business’s 50 day moving average is $0.35 and its two-hundred day moving average is $0.43. The company has a quick ratio of 1.05, a current ratio of 2.16 and a debt-to-equity ratio of 0.18. The stock has a market cap of $44.89 million, a price-to-earnings ratio of -4.00 and a beta of -0.20.

Xtant Medical (NYSEAMERICAN:XTNT) last released its quarterly earnings results on Tuesday, August 11th. The medical device company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.05). The firm had revenue of $23.03 million for the quarter, compared to analyst estimates of $24.88 million. Xtant Medical had a negative return on equity of 23.45% and a negative net margin of 10.17%.

Wall Street Analysts Forecast Growth

Separately, Loop Capital set a $1.00 price target on shares of Xtant Medical in a research note on Wednesday, September 2nd. Two analysts have rated the stock with a Buy rating. According to MarketBeat.com, Xtant Medical presently has a consensus rating of “Buy” and an average price target of $1.00.

Institutional Investors Weigh In On Xtant Medical

A hedge fund recently bought a new position in Xtant Medical stock. AWM Investment Company Inc. bought a new stake in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,976,910 shares of the medical device company’s stock, valued at approximately $2,516,000. AWM Investment Company Inc. owned 4.26% of Xtant Medical as of its most recent filing with the Securities and Exchange Commission (SEC). 69.33% of the stock is currently owned by institutional investors and hedge funds.

About Xtant Medical

Xtant Medical Holdings, Inc is a medical technology company focused on developing, manufacturing and distributing products used in orthopedic and spinal procedures. Its portfolio is designed to support bone growth, spinal fusion and the repair or reconstruction of musculoskeletal structures.

The company offers a range of biologic products, including human tissue allografts, demineralized bone matrix and other bone-graft substitutes. It also provides implantable devices and surgical instruments for spine and orthopedic applications, including products used in interbody fusion and spinal fixation procedures.

Xtant Medical is headquartered in Belgrade, Montana, and serves the U.S.